These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 10758776

  • 1. Characterization of the renal action of pranidipine in the rat.
    Nagahama T, Hayashi K, Fujiwara K, Ozawa Y, Saruta T.
    Arzneimittelforschung; 2000 Mar; 50(3):248-53. PubMed ID: 10758776
    [Abstract] [Full Text] [Related]

  • 2. Distinct action of aranidipine and its active metabolite on renal arterioles, with special reference to renal protection.
    Nakamura A, Hayashi K, Fujiwara K, Ozawa Y, Honda M, Saruta T.
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):942-8. PubMed ID: 10836731
    [Abstract] [Full Text] [Related]

  • 3. Role of protein kinase C in Ca channel blocker-induced renal arteriolar dilation in spontaneously hypertensive rats--studies in the isolated perfused hydronephrotic kidney.
    Hayashi K, Wakino S, Ozawa Y, Homma K, Kanda T, Okubo K, Takamatsu I, Tatematsu S, Kumagai H, Saruta T.
    Keio J Med; 2005 Jun; 54(2):102-8. PubMed ID: 16077260
    [Abstract] [Full Text] [Related]

  • 4. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T.
    Circ Res; 2007 Feb 16; 100(3):342-53. PubMed ID: 17307972
    [Abstract] [Full Text] [Related]

  • 5. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y, Hayashi K, Nagahama T, Fujiwara K, Saruta T.
    Hypertension; 2001 Sep 16; 38(3):343-7. PubMed ID: 11566902
    [Abstract] [Full Text] [Related]

  • 6. Altered renal microvascular response in Zucker obese rats.
    Hayashi K, Kanda T, Homma K, Tokuyama H, Okubo K, Takamatsu I, Tatematsu S, Kumagai H, Saruta T.
    Metabolism; 2002 Dec 16; 51(12):1553-61. PubMed ID: 12489067
    [Abstract] [Full Text] [Related]

  • 7. Effects of a calcium antagonist and an angiotensin II receptor antagonist on rat renal arterioles.
    Kimura K, Tojo A, Hirata Y, Hayakawa H, Goto A, Omata M.
    Blood Press Suppl; 1994 Dec 16; 5():71-4. PubMed ID: 7889206
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive agents and renal protection: calcium channel blockers.
    Saruta T, Kanno Y, Hayashi K, Konishi K.
    Kidney Int Suppl; 1996 Jun 16; 55():S52-6. PubMed ID: 8743511
    [Abstract] [Full Text] [Related]

  • 9. Disparate effects of calcium antagonists on renal microcirculation.
    Hayashi K, Nagahama T, Oka K, Epstein M, Saruta T.
    Hypertens Res; 1996 Mar 16; 19(1):31-6. PubMed ID: 8829821
    [Abstract] [Full Text] [Related]

  • 10. Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension.
    Hayashi K, Ozawa Y, Fujiwara K, Wakino S, Kumagai H, Saruta T.
    Am J Nephrol; 2003 Mar 16; 23(4):229-44. PubMed ID: 12840599
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cellular mechanism for mibefradil-induced vasodilation of renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Hayashi K, Ozawa Y, Wakino S, Kanda T, Homma K, Takamatsu I, Tatematsu S, Saruta T.
    J Cardiovasc Pharmacol; 2003 Dec 16; 42(6):697-702. PubMed ID: 14639089
    [Abstract] [Full Text] [Related]

  • 13. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats.
    Sabbatini M, Leonardi A, Testa R, Vitaioli L, Amenta F.
    Hypertension; 2000 Mar 16; 35(3):775-9. PubMed ID: 10720594
    [Abstract] [Full Text] [Related]

  • 14. T-type calcium channels in the regulation of afferent and efferent arterioles in rats.
    Feng MG, Li M, Navar LG.
    Am J Physiol Renal Physiol; 2004 Feb 16; 286(2):F331-7. PubMed ID: 14583435
    [Abstract] [Full Text] [Related]

  • 15. Renal afferent and efferent arteriolar dilation by nilvadipine: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y, Hayashi K, Nagahama T, Fujiwara K, Wakino S, Saruta T.
    J Cardiovasc Pharmacol; 1999 Feb 16; 33(2):243-7. PubMed ID: 10028932
    [Abstract] [Full Text] [Related]

  • 16. Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats.
    Fujiwara K, Kanno Y, Hayashi K, Takenaka T, Saruta T.
    Clin Exp Hypertens; 1998 Apr 16; 20(3):295-312. PubMed ID: 9605384
    [Abstract] [Full Text] [Related]

  • 17. [Effects of nisoldipine in heminephrectomized spontaneously hypertensive rats--measurement of afferent and efferent arterioles by microvascular cast].
    Maruyama T, Ono H, Ishimitsu T, Takanohashi A, Yagi S.
    Nihon Jinzo Gakkai Shi; 1993 Oct 16; 35(10):1123-30. PubMed ID: 8264103
    [Abstract] [Full Text] [Related]

  • 18. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct 16; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 19. Nephroprotective effect of treatment with calcium channel blockers in spontaneously hypertensive rats.
    Sabbatini M, Vitaioli L, Baldoni E, Amenta F.
    J Pharmacol Exp Ther; 2000 Sep 16; 294(3):948-54. PubMed ID: 10945845
    [Abstract] [Full Text] [Related]

  • 20. Vasodilatory effect of cilnidipine, an L-type and N-type calcium channel blocker, on rat kidney glomerular arterioles.
    Konno Y, Kimura K.
    Int Heart J; 2008 Nov 16; 49(6):723-32. PubMed ID: 19075488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.